Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0559 | 0.3035 | 0.2151 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1222 | 0.6913 | 1 |
Leishmania major | cysteine desulfhydrase | 0.0353 | 0.1831 | 0.2258 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0559 | 0.3035 | 0.2151 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1222 | 0.6913 | 0.7647 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1624 | 0.9263 | 1 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.0237 | 0.1152 | 0.2097 |
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | 0.0071 | 0.0177 | 1 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.1222 | 0.6913 | 1 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.1426 | 0.8106 | 1 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1222 | 0.6913 | 0.6521 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1426 | 0.8106 | 0.8751 |
Toxoplasma gondii | hypothetical protein | 0.0559 | 0.3035 | 0.5 |
Plasmodium falciparum | carbonic anhydrase | 0.0559 | 0.3035 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1624 | 0.9263 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1222 | 0.6913 | 1 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0559 | 0.3035 | 0.3298 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.1222 | 0.6913 | 0.6521 |
Entamoeba histolytica | acetyltransferase, putative | 0.0071 | 0.0177 | 0.0218 |
Wolbachia endosymbiont of Brugia malayi | 2,3,4,5-tetrahydropyridine-2,6-carboxylate N-succinyltransferase | 0.0071 | 0.0177 | 1 |
Schistosoma mansoni | carbonic anhydrase | 0.1426 | 0.8106 | 1 |
Mycobacterium tuberculosis | Probable serine acetyltransferase CysE (sat) | 0.0071 | 0.0177 | 0.0322 |
Echinococcus granulosus | carbonic anhydrase | 0.0559 | 0.3035 | 0.4243 |
Echinococcus granulosus | carbonic anhydrase | 0.0559 | 0.3035 | 0.4243 |
Mycobacterium leprae | Probable transmembrane transport protein | 0.0237 | 0.1152 | 0.1247 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.1222 | 0.6913 | 1 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0979 | 0.549 | 1 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1624 | 0.9263 | 1 |
Onchocerca volvulus | 0.0206 | 0.0965 | 1 | |
Mycobacterium ulcerans | transferase | 0.0068 | 0.0161 | 0.0174 |
Echinococcus granulosus | carbonic anhydrase | 0.0559 | 0.3035 | 0.4243 |
Onchocerca volvulus | Putative sulfate transporter | 0.0206 | 0.0965 | 1 |
Echinococcus multilocularis | carbonic anhydrase II | 0.1222 | 0.6913 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0559 | 0.3035 | 0.2151 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0559 | 0.3035 | 0.3298 |
Leishmania major | carbonic anhydrase-like protein | 0.1222 | 0.6913 | 0.8528 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0882 | 0.4924 | 0.8969 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0781 | 0.4333 | 0.7893 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1222 | 0.6913 | 0.7647 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0559 | 0.3035 | 0.3298 |
Entamoeba histolytica | ankyrin, putative | 0.0071 | 0.0177 | 0.0218 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1426 | 0.8106 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0559 | 0.3035 | 0.3298 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0559 | 0.3035 | 0.3298 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1222 | 0.6913 | 1 |
Echinococcus granulosus | carbonic anhydrase II | 0.1222 | 0.6913 | 1 |
Leishmania major | carbonic anhydrase family protein, putative | 0.1426 | 0.8106 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.